Document is current
Any future updates will be listed below
-
Authors
Wnorowski, Susan https://orcid.org/0000-0002-9659-4784
Niemoller, Faith https://orcid.org/0009-0001-7601-0913
Glaetzer, Anja https://orcid.org/0000-0002-4521-3419
Tamburri, Robert https://orcid.org/0009-0009-3304-4994
Vine, Elissa https://orcid.org/0009-0006-6577-0729
Flick, Franziska https://orcid.org/0009-0006-0121-7545
Patel, Meera https://orcid.org/0000-0002-3792-8879
Hermes-DeSantis, Evelyn R. https://orcid.org/0000-0001-5658-3899
- License Information
-
More Information
Article History
Accepted: 3 December 2025
First Online: 20 January 2026
Declarations
:
: Susan Wnorowski is employed by Ipsen, and owns stock in Ipsen Biopharmaceuticals, Inc. Faith Niemoller is employed by Biogen, at the time of manuscript development she was employed by Eli Lilly and company and owns stock in Eli Lilly and Company. Anja Glaetzer is employed by Sanofi, and owns stock in Sanofi and Johnson & Johnson. Robert Tamburri is employed by J&J, and owns stock in Johnson & Johnson. Elissa Vine is employed by J&J and owns stock in Johnson & Johnson. Franziska Flick is employed by Merck KGaA, Darmstadt, Germany. Meera Patel is employed by Bayer, and owns stock in Bayer. Evelyn R. Hermes-DeSantis is employed by phactMI.
: Not applicable.
: All surveys were voluntarily completed by participants. All data were anonymized.
: Not applicable.
: Data sharing is not applicable to this article as no datasets were generated or analyzed during the current study.
: No coding was used in the article.
: All authors substantially contributed to all aspects of authorship, including conception and design; interpretation; drafting and revising the final work. All authors read and approved the final manuscript draft for submission and agreed to be accountable for all aspects of the work.
